Sexual Dysfunction Signals Early Autonomic Involvement in Rare Hereditary Transthyretin Amyloidosis
A case report details how sexual dysfunction served as the earliest prodromal sign of autonomic neuropathy in a patient with ...
A case report details how sexual dysfunction served as the earliest prodromal sign of autonomic neuropathy in a patient with ...
A comprehensive clinical review details how molecular diagnostics, artificial intelligence, and targeted therapies are reshaping the management of transthyretin amyloid ...
Researchers have developed and validated a claims-based algorithm that identifies transthyretin amyloid cardiomyopathy cases in administrative databases with high accuracy ...
A retrospective observational study of 3,239 American patients receiving tafamidis for transthyretin amyloid cardiomyopathy found substantial rates of cardiovascular hospitalization ...
A published viewpoint proposes an updated clinical trial framework that broadens heart failure endpoint definitions to capture the distinctive pathophysiology ...
A German prescription database analysis of 289 patients found acoramidis was initiated mainly as first-line therapy for older, predominantly male ...
A new review finds that women with transthyretin amyloid cardiomyopathy face diagnostic delays of up to five years because sex-blind ...
A newly published protocol details ACO-SWITCH, a phase 4 single-arm study that will measure serum transthyretin changes in 50 adults ...
A matched real-world cohort analysis found that patients with transthyretin amyloid cardiomyopathy treated with tafamidis had a 74% lower risk ...
A post hoc analysis of the ATTR-ACT trial found that 64 percent of tafamidis-treated patients maintained walking-distance stability at 12 ...
A post hoc analysis of the ATTR-ACT trial and its long-term extension found continuous tafamidis treatment significantly reduced cardiovascular death ...
A post hoc analysis of the ATTR-ACT trial found that early increases in TTR concentration after tafamidis treatment were associated ...
A chart review of 54 patients with hereditary transthyretin amyloidosis found that only a third of coded polyneuropathy diagnoses were ...
A pooled analysis of 1924 tafamidis-treated patients found women made up 11.1 percent of the cohort, more often carried hereditary ...
A pooled real-world analysis of 1,924 patients with transthyretin amyloid cardiomyopathy treated with tafamidis found that outcomes in patients aged ...
A retrospective US claims analysis found that newly treated ATTR-CM patients starting acoramidis had significantly lower risks of diuretic intensification ...
A retrospective multicenter study found that neurologic, cardiac, nutritional and frailty measures were largely maintained over at least 12 months ...
A new EJNMMI Reports commentary synthesizes a landmark article collection showing how PET tracers, SPECT/CT, artificial intelligence and whole-body imaging ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.